26 March 2018

TIKOMED CEO IS PANELIST AT EUROPE CEO IN AMSTERDAM

TikoMeds CEO represented TikoMed at the Europe CEO meeting prior to the BIO Europe spring event.
The panel discussed the topic of how to build a biotech company in Europe. Several parts of the structural process was touched upon but in essence the panelists concurred that people, in every aspect is the essence. The chain from founders, owners, board, management and staff needs to be crisp, diligent and professional. In turn that will provide for efficient positioning, funding, strategy and execution of plans.

DATE
TBA

TIME
TBA

VENUE
TBA

OTHER NEWS

2 November 2018
First patient treated with ILB in TIKOMED’s clinical trial for ALS
Viken, November 2nd, 2018 — TIKOMED, a specialty pharmaceutical company focused on developing therapeutics for…
Read More
20 August 2018
TIKOMED to initiate ALS clinical trial for which the UK Medicines and Healthcare products Regulatory Agency has granted permission
Viken, August 20th, 2018 — TIKOMED, a specialty pharmaceutical company focused on developing therapeutics for…
Read More
14 August 2018
TIKOMED Announce Start of ALS Study at Sahlgrenska University Hospital
VIKEN, Sweden, August 14, 2018 – ​TIKOMED, a specialty pharmaceutical company focused on developing therapeutics…
Read More
SEE MORE